Literature DB >> 7480692

Osteoid osteoma: percutaneous radio-frequency ablation.

D I Rosenthal1, D S Springfield, M C Gebhardt, A E Rosenberg, H J Mankin.   

Abstract

PURPOSE: To evaluate a percutaneous technique for in situ destruction of osteoid osteoma.
MATERIALS AND METHODS: Radio-frequency ablation was performed in 18 patients with osteoid osteoma (17 male, one female; age range, 8-42 years). Diagnosis was established by means of clinical and radiographic features and confirmed by means of needle biopsy findings. No attempt was made to remove the lesion. A small radio-frequency electrode introduced into the lesion through the biopsy track was used to produce thermal necrosis of a 1-cm sphere of tissue.
RESULTS: Symptoms were completely relieved in 16 (89%) of 18 patients. In one patient, a second procedure was required for pain relief. All but two patients underwent treatment as outpatients: These two were hospitalized for 1 night only. All patients resumed normal daily activities immediately. No casts or external supports were required; there were no complications. Twelve patients were followed up for more than 1 year. There were no recurrences
CONCLUSION: Radio-frequency ablation of osteoid osteoma is a promising alternative to surgery in selected patients.

Entities:  

Mesh:

Year:  1995        PMID: 7480692     DOI: 10.1148/radiology.197.2.7480692

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  52 in total

Review 1.  Current trends in treatment of osteoid osteoma with an emphasis on radiofrequency ablation.

Authors:  Colin P Cantwell; John Obyrne; Stephen Eustace
Journal:  Eur Radiol       Date:  2003-12-09       Impact factor: 5.315

2.  CT-guided radiofrequency ablation of osteoid osteoma in the long bones of the lower extremity.

Authors:  Yoshiki Asayama; Akihiro Nishie; Kousei Ishigami; Daisuke Kakihara; Yasuhiro Ushijima; Yukihisa Takayama; Nobuhiro Fujita; Tsuyoshi Tajima; Kengo Yoshimitsu; Shuichi Matsuda; Yukihide Iwamoto; Hiroshi Honda
Journal:  World J Radiol       Date:  2012-06-28

Review 3.  Paediatric musculoskeletal interventional radiology.

Authors:  Gian L Natali; Guglielmo Paolantonio; Rodolfo Fruhwirth; Giuseppe Alvaro; George K Parapatt; Paolo Toma'; Massimo Rollo
Journal:  Br J Radiol       Date:  2015-09-23       Impact factor: 3.039

4.  Expert's Comment concerning Grand Rounds case entitled "Diagnosis and treatment of a C2-osteoblastoma encompassing the vertebral artery" (by Stavros I. Stavridis, Andreas Pingel, Klaus John Schnake and Frank Kandziora).

Authors:  Osmar J S Moraes
Journal:  Eur Spine J       Date:  2013-11-07       Impact factor: 3.134

5.  Experience of neuroprotective air injection during radiofrequency ablation (RFA) of spinal osteoid osteoma.

Authors:  Alessandro Vidoni; Melvin Grainger; Steven James
Journal:  Eur Radiol       Date:  2018-04-12       Impact factor: 5.315

Review 6.  Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem.

Authors:  Matthew R Callstrom; J William Charboneau; Matthew P Goetz; Joseph Rubin; Thomas D Atwell; Michael A Farrell; Timothy J Welch; Timothy P Maus
Journal:  Skeletal Radiol       Date:  2005-10-05       Impact factor: 2.199

Review 7.  The future of MSK interventions.

Authors:  Daniel I Rosenthal
Journal:  Skeletal Radiol       Date:  2011-09       Impact factor: 2.199

Review 8.  Percutaneous ablation for bone and soft tissue metastases--why cryoablation?

Authors:  Matthew R Callstrom; A Nick Kurup
Journal:  Skeletal Radiol       Date:  2009-09       Impact factor: 2.199

9.  Radiofrequency thermoablation of primary non-spinal osteoid osteoma: optimization of the procedure.

Authors:  E Rimondi; Giuseppe Bianchi; M C Malaguti; R Ciminari; A Del Baldo; M Mercuri; U Albisinni
Journal:  Eur Radiol       Date:  2005-03-09       Impact factor: 5.315

10.  Radiofrequency resection of bronchial tumours in combination with cryotherapy: evaluation of a new technique.

Authors:  A Marasso; V Bernardi; R Gai; E Gallo; G M Massaglia; M Onoscuri; S B Cardaci
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.